New authorization IMP (CAPSULES and BIOLOGICAL PRODUCTS)
November 24, 2022Fulton received from AIFA a new authorization for the Investigational Medicinal Product (IMP) production of biological products in hard capsules.
Fulton received from AIFA a new authorization for the Investigational Medicinal Product (IMP) production of biological products in hard capsules.